Karabelas Argeris N
- SEC CIK
- 0001191229
No open-market purchases or sales filed in the past year.
Current role at each company
- RGNX REGENXBIO Inc.Directoras of Jun 2, 2026
- BHC Bausch Health Companies Inc.Directoras of Jun 28, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Karabelas Argeris N as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RGNX REGENXBIO Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2024 (view filing) | Oct 1 | 1 day | Karabelas Argeris NDirector | SSale | −10.0K | $10.11 | −$101.1K | −47.0%11.3K after | 10b5-1 |
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Karabelas Argeris NDirector | SSale | −10.0K | $11.56 | −$115.6K | −47.0%11.3K after | 2 lots10b5-1 |
| Aug 5, 2024 (view filing) | Aug 1 | 4 days | Karabelas Argeris NDirector | SSale | −10.1K | $13.51 | −$136.5K | −47.2%11.3K after | 3 lots10b5-1 |
| Jul 30, 2024 (view filing) | Jul 29 | 1 day | Karabelas Argeris NDirector | SSale | −11.0K | $15.05 | −$165.6K | −49.4%11.3K after | 10b5-1 |
| Jul 3, 2024 (view filing) | Jul 1 | 2 days | Karabelas Argeris NDirector | SSale | −10.0K | $11.27 | −$112.7K | −47.0%11.3K after | 10b5-1 |